Cytogenetic and Molecular Biology for Acute Leukemias at Diagnosis: A Cost/Effectiveness Comparison

References

• Hoelzer D. F. Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematology/oncology clinics of North America. 1993; 7(1)139–160
   PubMed Web of Science ®Google Scholar
• Vogler W. Strategies in the treatment of acute myelogenous leukemia. Leukemia Research 1992; 16(12)1141–1153
   Web of Science ®Google Scholar
• Baer M., Bloomfield C. D. Cytogenetics and oncogenes in leukemia. Current Opinion Oncology 1992; 4: 24–32
   PubMedGoogle Scholar
• Lestingi T. M., Hooberman A. L. Philadelphia chromosome positive acute lymphoblastic leukemia. Hematology Oncology Clinics North America 1993; 7: 161–175
   PubMed Web of Science ®Google Scholar
• The groupe français de cytogénétique hématologique. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the groupe francais de cytogénéque hématologique. Blood 1996; 87(8)3135–3142
   PubMed Web of Science ®Google Scholar
• Hunger S. P., Galili N., Carroll A. J., Crist W. M., Link M. P., Cleary M. L. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 1991; 77: 687–693
   PubMed Web of Science ®Google Scholar
• Dastugue N., Payen C., Lafage-Pochitaloff M., et al. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia 1995; 9: 1491–1498
   PubMed Web of Science ®Google Scholar
• Bloomfield C. D. Prognostic factors for selective curative therapy for adult acute myeloid leukemia. Leukemia 1995; 9: 65–67
   Google Scholar
• Coiffier B., Philip T., Burnett A., Symann M. Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies: Lyon, France, June 4–6, 1993. Journal of Clinical Oncology 1994; 12(1)226–231
   PubMed Web of Science ®Google Scholar
• Gabert J., Bilhou-Nabera C., Macintyre E., et al. Prospective multicentric molecular study for poor prognosis fusion transcripts at diagnosis in adult patients-Lala94 trial. Blood 1996; 80: 76a, (supp 1)n
   Google Scholar
• Mauer J., Janssen J. W. G., Thiel E., et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukemia by the polymerase chain reaction. The Lancet 1991; 337: 1055–1058
   PubMed Web of Science ®Google Scholar
• Poirel H., Rack K., Delabesse E., et al. Incidence and characterization of MLL gene (llq23) rearrangements in acute myeloid leukemia M1 and M5. Blood 1996; 87(6)2496–2505
   PubMed Web of Science ®Google Scholar
• Biondi A., Rambaldi A., Rossi V., et al. Detection of ALL-1/AF4 fusion transcript by reverse transcription polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood 1993; 82(10)2943–2947
   PubMed Web of Science ®Google Scholar
• Hirtzlin I., Mandel J. L., Lanoe J. L., Fardeau-Gauthier M. Analyse comparée du coût des techniques cytogénétiques et de biologie moléculaire dans le diagnostic de la maladie de l'X fragile. Revue Epidémiologie et Santé Publique 1995; 43: 205–214
   PubMedGoogle Scholar
• Drummond M. F., Stoddard G. L., Torrance G. W. Methods for the economic evaluation of health care programmes. Publications OM, Oxford 1987
   Google Scholar
• Costello R., Lafage M., Toiron Y., Brunei V., Sainty D., Arnoulet C., Mozziconacci M. J., Bouabdallah R., Gastaut J. A., Maraninchi D., Gabert J. Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases. British Journal of Haematology 1995; 90: 346–352
   PubMed Web of Science ®Google Scholar
• Kwok K., Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237–238
   PubMed Web of Science ®Google Scholar
• Seeker-Walker L. M. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1990; 49: 1–13
   PubMed Web of Science ®Google Scholar
• Fenaux P., Preudhomme C., Laï J. L., Morel P., Beuscart R., Bauters F. Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases. British Journal of Haematology 1989; 73: 61–67
   PubMed Web of Science ®Google Scholar
• Arthur D. C., Berger R., Golomb H. M., et al. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet 1989; 40: 203–216
   PubMed Web of Science ®Google Scholar
• Luce B. R., Elixhauer A. Estimating costs in the economic valuation of medical technologies. International Journal of Technology Assessment in Health Care 1990; 6: 57–75
   PubMedGoogle Scholar
• Serror V., Moatti J. P. La mesure des coûts de stratégies médicales dans les analyses économiques: Un exercice pas si simple. Le Courrier de l'évaluation en santé 1993; 2: 5–7
   Google Scholar
• Mitelman F., Hiem S. Quantitative acute leukemia cytogenetics. Genes, Chromosomes & Cancer 1992; 5: 57–66
   PubMed Web of Science ®Google Scholar
• Heim S. Is cancer cytogenetics reducible to the molecular genetics of cancer cells?. Genes, Chromosomes & Cancer 1992; 5: 188–196
   PubMed Web of Science ®Google Scholar
• Chouaid C., Roux P., Lavard I., Poirot J. L., Housset B. Use of the polymerase chain reaction technique on induced-sputum samples for the diagnosis of Pneumocystis carinii pneumonia in HIV-infected patients. A clinical and cost analysis study. Clinical Microbiology and Infectious Disease 1995; 104(1)72–75
   Google Scholar
• Chen Z., Morgan R., Stone J. F., Sandberg A. A. A useful technique in the verification of clonality of random chromosome abnormalities. Cancer Genet Cytogenet 1993; 66: 73–74
   PubMed Web of Science ®Google Scholar
• Hagemeijer A., Buijs A., Smit E., et al. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by Fish in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosome Cancer 1993; 8: 237–245
   PubMed Web of Science ®Google Scholar